Rapidly Progressive Pleuro-parenchymal Fibroelastosis Secondary to Cyclophosphamide Chemotherapy

Author:

Bhaskar Maheema1,Tisekar Owais1,Tandon Sandeep1,Vora Tushar2,Jankharia Bhavin3

Affiliation:

1. Department of Pulmonary Medicine, Tata Memorial Hospital and Homi Bhabha National Institute, Mumbai, Maharashtra, India

2. Department of Pediatric Oncology, Tata Memorial Hospital and Homi Bhabha National Institute, Mumbai, Maharashtra, India

3. Consultant Radiologist and Partner, Dr. Jankharia's Imaging Centre, Mumbai, Maharashtra, India

Abstract

AbstractPleuroparenchymal fibroelastosis (PPFE) is a rare progressive interstitial lung disease presenting with predominantly upper-lobe pleural thickening and pulmonary fibrosis. While most cases are idiopathic, it is rarely seen as a complication of infection or following chemotherapy, radiation therapy, and bone marrow transplant. We describe a case of early onset and rapidly progressive PPFE as a complication of cyclophosphamide chemotherapy.

Publisher

Georg Thieme Verlag KG

Subject

Oncology,Pediatrics, Perinatology and Child Health

Reference11 articles.

1. Early increases in pulmonary mRNA encoding procollagens and transforming growth factor-beta in mice sensitive to cyclophosphamide-induced pulmonary fibrosis;D G Hoyt;J Pharmacol Exp Ther,1989

2. Pleuroparenchymal fibroelastosis: Its clinical characteristics;K Watanabe;Curr Respir Med Rev,2013

3. Idiopathic pleuroparenchymal fibroelastosis: Description of a novel clinicopathologic entity;S K Frankel;Chest,2004

4. An official American thoracic society/European respiratory society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias;W D Travis;Am J Respir Crit Care Med,2013

5. Histological evolution of pleuroparenchymal fibroelastosis;T Hirota;Histopathology,2015

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3